MOESM1 of Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial
journal contributionposted on 2019-12-12, 12:11 authored by David Palma, Hanbo Chen, Houda Bahig, Stewart Gaede, Stephen Harrow, Joanna Laba, X. Qu, George Rodrigues, Brian P. Yaremko, Edward Yu, Alexander Louie, Inderdeep Dhaliwal, Christopher Ryerson
Additional file 1. Â Summary of SABR-related mortality and ILD-specific toxicity. Reproduced from Chen et al .